Literature DB >> 25820865

Assessing individual risk for high-risk colorectal adenoma at first-time screening colonoscopy.

Kana Wu1, Edward L Giovannucci1,2,3, Yin Cao1,2, Bernard A Rosner3,4, Jing Ma2,3, Rulla M Tamimi2,3, Andrew T Chan3,5, Charles S Fuchs3,6.   

Abstract

Assessing risk of colorectal adenoma at first-time colonoscopy that are of higher likelihood of developing advanced neoplasia during surveillance could help tailor first-line colorectal cancer screening. We developed prediction models for high-risk colorectal adenoma (at least one adenoma ≥1 cm, or with advanced histology, or ≥3 adenomas) among 4,881 asymptomatic white men and 17,970 women who underwent colonoscopy as their first-time screening for colorectal cancer in two prospective US studies using logistic regressions. C-statistics and Hosmer-Lemeshow tests were used to evaluate discrimination and calibration. Ten-fold cross-validation was used for internal validation. A total of 330 (6.7%) men and 678 (3.8%) women were diagnosed with high-risk adenoma at first-time screening colonoscopy. The model for men included age, family history of colorectal cancer, BMI, smoking, sitting watching TV/VCR, regular aspirin/NSAID use, physical activity, and a joint term of multivitamin and alcohol. For women, the model included age, family history of colorectal cancer, BMI, smoking, alcohol, beef/pork/lamb as main dish, regular aspirin/NSAID, calcium, and oral contraceptive use. The C-statistic of the model for men was 0.67 and 0.60 for women (0.64 and 0.57 in cross-validation). Both models calibrated well. The predicted risk of high-risk adenoma for men in the top decile was 15.4% vs. 1.8% for men in the bottom decile (Odds Ratio [OR] = 9.41), and 6.6% vs. 2.1% for women (OR = 3.48). In summary, we developed and internally validated an absolute risk assessment tool for high-risk colorectal adenoma among the US population that may provide guidance for first-time colorectal cancer screening.
© 2015 UICC.

Entities:  

Keywords:  colonoscopy; colorectal adenoma; risk prediction; screening

Mesh:

Year:  2015        PMID: 25820865      PMCID: PMC4503471          DOI: 10.1002/ijc.29533

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  58 in total

1.  Internal validation of predictive models: efficiency of some procedures for logistic regression analysis.

Authors:  E W Steyerberg; F E Harrell; G J Borsboom; M J Eijkemans; Y Vergouwe; J D Habbema
Journal:  J Clin Epidemiol       Date:  2001-08       Impact factor: 6.437

2.  Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses' Health Study.

Authors:  G A Colditz; B Rosner
Journal:  Am J Epidemiol       Date:  2000-11-15       Impact factor: 4.897

3.  Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.

Authors:  Sha Tao; Michael Hoffmeister; Hermann Brenner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-08       Impact factor: 11.382

4.  Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention.

Authors:  B Rockhill; D Spiegelman; C Byrne; D J Hunter; G A Colditz
Journal:  J Natl Cancer Inst       Date:  2001-03-07       Impact factor: 13.506

Review 5.  The advanced adenoma as the primary target of screening.

Authors:  Sidney J Winawer; Ann G Zauber
Journal:  Gastrointest Endosc Clin N Am       Date:  2002-01

6.  Harvard report on cancer prevention volume 4: Harvard Cancer Risk Index. Risk Index Working Group, Harvard Center for Cancer Prevention.

Authors:  G A Colditz; K A Atwood; K Emmons; R R Monson; W C Willett; D Trichopoulos; D J Hunter
Journal:  Cancer Causes Control       Date:  2000-07       Impact factor: 2.506

7.  Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia.

Authors:  Jaroslaw Regula; Maciej Rupinski; Ewa Kraszewska; Marcin Polkowski; Jacek Pachlewski; Janina Orlowska; Marek P Nowacki; Eugeniusz Butruk
Journal:  N Engl J Med       Date:  2006-11-02       Impact factor: 91.245

8.  Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis.

Authors:  Daniela Schmid; Michael F Leitzmann
Journal:  J Natl Cancer Inst       Date:  2014-06-16       Impact factor: 13.506

9.  A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy.

Authors:  Michal F Kaminski; Marcin Polkowski; Ewa Kraszewska; Maciej Rupinski; Eugeniusz Butruk; Jaroslaw Regula
Journal:  Gut       Date:  2014-01-02       Impact factor: 23.059

10.  Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.

Authors:  Ruth M Pfeiffer; Yikyung Park; Aimée R Kreimer; James V Lacey; David Pee; Robert T Greenlee; Saundra S Buys; Albert Hollenbeck; Bernard Rosner; Mitchell H Gail; Patricia Hartge
Journal:  PLoS Med       Date:  2013-07-30       Impact factor: 11.069

View more
  12 in total

1.  Molecular Biologic and Epidemiologic Insights for Preventability of Colorectal Cancer.

Authors:  Edward Giovannucci
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

2.  Favorable lifestyle before diagnosis associated with lower risk of screen-detected advanced colorectal neoplasia.

Authors:  Markus D Knudsen; Thomas de Lange; Edoardo Botteri; Dung-Hong Nguyen; Helge Evensen; Chloé B Steen; Geir Hoff; Tomm Bernklev; Anette Hjartåker; Paula Berstad
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

3.  Epigenetics and Colorectal Neoplasia: the Evidence for Physical Activity and Sedentary Behavior.

Authors:  Elizabeth Hibler
Journal:  Curr Colorectal Cancer Rep       Date:  2015-09-19

4.  Aspirin, ibuprofen, and reduced risk of advanced colorectal adenoma incidence and recurrence and colorectal cancer in the PLCO Cancer Screening Trial.

Authors:  Kenechukwu Chudy-Onwugaje; Wen-Yi Huang; L Joseph Su; Mark P Purdue; Christine C Johnson; Lingxiao Wang; Hormuzd A Katki; Kathryn Hughes Barry; Sonja I Berndt
Journal:  Cancer       Date:  2021-05-11       Impact factor: 6.921

5.  Clinicopathologic distribution of KRAS and BRAF mutations in a Chinese population with colorectal cancer precursor lesions.

Authors:  Chenghao Yi; Yanqing Huang; Xing Yu; Xiaofen Li; Shu Zheng; Kefeng Ding; Jinghong Xu
Journal:  Oncotarget       Date:  2016-03-29

6.  Strongly enhanced colorectal cancer risk stratification by combining family history and genetic risk score.

Authors:  Korbinian Weigl; Jenny Chang-Claude; Phillip Knebel; Li Hsu; Michael Hoffmeister; Hermann Brenner
Journal:  Clin Epidemiol       Date:  2018-01-19       Impact factor: 4.790

Review 7.  Epidemiology and biology of physical activity and cancer recurrence.

Authors:  Christine M Friedenreich; Eileen Shaw; Heather K Neilson; Darren R Brenner
Journal:  J Mol Med (Berl)       Date:  2017-06-15       Impact factor: 4.599

8.  Head-to-Head Comparison of the Performance of 17 Risk Models for Predicting Presence of Advanced Neoplasms in Colorectal Cancer Screening.

Authors:  Le Peng; Yesilda Balavarca; Korbinian Weigl; Michael Hoffmeister; Hermann Brenner
Journal:  Am J Gastroenterol       Date:  2019-09       Impact factor: 10.864

9.  Determining Risk of Colorectal Cancer and Starting Age of Screening Based on Lifestyle, Environmental, and Genetic Factors.

Authors:  Jihyoun Jeon; Mengmeng Du; Robert E Schoen; Michael Hoffmeister; Polly A Newcomb; Sonja I Berndt; Bette Caan; Peter T Campbell; Andrew T Chan; Jenny Chang-Claude; Graham G Giles; Jian Gong; Tabitha A Harrison; Jeroen R Huyghe; Eric J Jacobs; Li Li; Yi Lin; Loïc Le Marchand; John D Potter; Conghui Qu; Stephanie A Bien; Niha Zubair; Robert J Macinnis; Daniel D Buchanan; John L Hopper; Yin Cao; Reiko Nishihara; Gad Rennert; Martha L Slattery; Duncan C Thomas; Michael O Woods; Ross L Prentice; Stephen B Gruber; Yingye Zheng; Hermann Brenner; Richard B Hayes; Emily White; Ulrike Peters; Li Hsu
Journal:  Gastroenterology       Date:  2018-02-17       Impact factor: 33.883

10.  Immunohistochemical expression of heparanase isoforms and syndecan-1 proteins in colorectal adenomas.

Authors:  J Waisberg; T R Theodoro; L L Matos; F B Orlandi; R L Serrano; G T Saba; M A S Pinhal
Journal:  Eur J Histochem       Date:  2016-02-17       Impact factor: 3.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.